GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

In a major strategic shift, GlaxoSmithKline (GSK) has finalized an agreement to acquire Novartis' 36.5% stake in their consumer healthcare joint venture for $13 billion. ... Read More